Liver, breast, intestinal, and pancreatic cancers as well as common male and female reproductive cancers, have clinically significant tumor markers used to monitor disease progression. Enzyme immunoassays (EIAs) are the gold standard technology used for the quantitative determination of tumor markers including AFP, CA-125, CA15-3, CA19-9, CEA, PSA and Free PSA.
Free PSA (Prostate Specific Antigen) ELISA Kit (CE)
The Free PSA ELISA Kit is intended for the measurement of free prostate specific antigen in a sample. Kit has a lead time of 1 week from order receipt.